Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults A Delphi Expert Consensus /

Background/Objectives: Vitamin B12 deficiency can cause variable symptoms, which may be irreversible if not diagnosed and treated in a timely manner. We aimed to develop a widely accepted expert consensus to guide the practice of diagnosing and treating B12 deficiency. Methods: We conducted a scopin...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Obeid Rima
Andrès Emmanuel
Češka Richard
Hooshmand Babak
Guéant-Rodriguez Rosa-Maria
Prada Gabriel Ioan
Sławek Jarosław
Traykov Latchezar
Ta Van Binh
Várkonyi Tamás
Reiners Karlheinz
Kollaborációs szervezet: The Vitamin B12 Consensus Panelists Group
et al
Dokumentumtípus: Cikk
Megjelent: 2024
Sorozat:JOURNAL OF CLINICAL MEDICINE 13 No. 8
Tárgyszavak:
doi:10.3390/jcm13082176

mtmt:34788761
Online Access:http://publicatio.bibl.u-szeged.hu/30121
Leíró adatok
Tartalmi kivonat:Background/Objectives: Vitamin B12 deficiency can cause variable symptoms, which may be irreversible if not diagnosed and treated in a timely manner. We aimed to develop a widely accepted expert consensus to guide the practice of diagnosing and treating B12 deficiency. Methods: We conducted a scoping review of the literature published in PubMed since January 2003. Data were used to design a two-round Delphi survey to study the level of consensus among 42 experts. Results: The panelists agreed on the need for educational and organizational changes in the current medical practices for diagnosing and treating B12 deficiency. Recognition of clinical symptoms should receive the highest priority in establishing the diagnosis. There is agreement that the serum B12 concentration is useful as a screening marker and methylmalonic acid or homocysteine can support the diagnosis. Patient lifestyle, disease history, and medications can provide clues to the cause of B12 deficiency. Regardless of the cause of the deficiency, initial treatment with parenteral B12 was regarded as the first choice for patients with acute and severe manifestations of B12 deficiency. The use of high-dose oral B12 at different frequencies may be considered for long-term treatment. Prophylactic B12 supplementation should be considered for specific high-risk groups. Conclusions: There is a consensus that clinical symptoms need to receive more attention in establishing the diagnosis of B12 deficiency. B12 laboratory markers can support the diagnosis. The severity of clinical symptoms, the causes of B12 deficiency, and the treatment goals govern decisions regarding the route and dose of B12 therapy.
Terjedelem/Fizikai jellemzők:18
ISSN:2077-0383